Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab

Archives of Dermatology

Volumn 144, Issue 12, 2008, Pages 1662-1663

  Bard, Susan ^b   Paravisini, Alexandra ^b   Avilés Izquierdo, José Antonio ^b   Fernandez Cruz, Eduardo ^b   Sánchez Ramón, Silvia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OMALIZUMAB; STEROID; TACROLIMUS;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG TREATMENT FAILURE; ECZEMA; FEMALE; HUMAN; HYPER IGE SYNDROME; LETTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ECZEMA; FEMALE; HUMANS; IMMUNOGLOBULIN E; JOB'S SYNDROME; TREATMENT OUTCOME;

EID: 58049211757     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.510     Document Type: Letter

References (6)

1. Ohameje NU, Loveless JW, Saini SS. Atopic dermatitis or hyper IgE syndrome. Allergy Asthma Proc. 2006;27(3):289-291.
2. Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol. 2000;11(3):133-141.
3. Eberting CL, Davis J, Puck JM, Holland SM, Turner ML. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004;140(9):1119-1125.
4. Grimbacher B, Schäffer AA, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65(3):735-744.
5. Krathen RA, Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol. 2005;53(2):338-340.
6. Vigo PG, Girgis KR, Pfuetze BL, Critchlow ME, Fisher J, Hussain I. Efficacy of anti-IgE therapy in patients with atopic dermatitis. J Am Acad Dermatol. 2006;55(1):168-170.